458 filings
Page 3 of 23
10-Q
2016 Q2
CRXM
Gene Biotherapeutics, Inc.
Quarterly report
6 Mar 17
12:00am
10-Q
2016 Q1
CRXM
Gene Biotherapeutics, Inc.
Quarterly report
1 Mar 17
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
10 Jan 17
Regulation FD Disclosure
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
5 Jan 17
Regulation FD Disclosure
12:00am
SC 13G/A
Sabby Management, LLC
5 Jan 17
Taxus Cardium Pharmaceuticals Group Inc.
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
4 Jan 17
Angionetics to Present at Two San Francisco-based Healthcare
12:00am
10-K
2015 FY
CRXM
Gene Biotherapeutics, Inc.
Annual report
29 Dec 16
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
14 Dec 16
Taxus Cardium Announces Two Director Retirements
12:00am
NT 10-Q
CRXM
Gene Biotherapeutics, Inc.
15 Nov 16
Notice of late quarterly filing
12:00am
10-Q
2015 Q3
CRXM
Gene Biotherapeutics, Inc.
Quarterly report
27 Oct 16
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
3 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
27 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
13 Sep 16
Other Events
12:00am
10-Q
2015 Q2
CRXM
Gene Biotherapeutics, Inc.
Quarterly report
29 Aug 16
12:00am
NT 10-Q
CRXM
Gene Biotherapeutics, Inc.
16 Aug 16
Notice of late quarterly filing
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
11 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
CRXM
Gene Biotherapeutics, Inc.
11 Jul 16
Angionetics & a Huapont Life Sciences Affiliate Enter Agreement
12:00am
NT 10-Q
CRXM
Gene Biotherapeutics, Inc.
16 May 16
Notice of late quarterly filing
12:00am
NT 10-K
CRXM
Gene Biotherapeutics, Inc.
31 Mar 16
Notice of late annual filing
12:00am
SC 13G/A
Sabby Management, LLC
5 Jan 16
Taxus Cardium Pharmaceuticals Group Inc.
12:00am